Two Undervalued Healthcare Stocks with 60%+ Upside Potential
Two UNDERVALUED healthcare stocks that could run 60%+ in the next year? Yes, please. 🚀 Who’s hunting for healthcare gems in this beat-up sector? 🙋♂️🙋♀️ These two are flying under the radar — let’s talk. The healthcare sector has drastically underperformed the broader market over the past year. Yet, within the beaten-down space, several undervalued stocks now show strong upside potential. Some analysts believe these two companies could rally at least 60% in the next 12 months: Viking Therapeutics (VKTX) and HCA Healthcare (HCA). $Viking Therapeutics(VKTX)$ Over the past few years, Viking Therapeutics has emerged as a high-profile name in biotechnology, driven by its pipeline of next-generation weight-loss drugs. Since the FDA approv
Growing Faster Than NVIDIA? These 2 Tech Companies Did It
Think NVIDIA’s growth is unbeatable? These two just OUTGROWED it. Who’s holding either of these AI powerhouses? Let’s discuss! Amid the current AI investment boom, NVIDIA has undoubtedly been the most high-profile stock. As a company with a market capitalization of $4 trillion, it has posted triple-digit revenue growth for multiple consecutive quarters. Even in the latest quarter, its revenue surged 73% year-over-year—a pace few companies can match. Yet a small group of tech firms have still managed to grow even faster than NVIDIA, making them worth watching closely. $Micron Technology(MU)$ Micron Technology posted revenue of $23.9 billion in its fiscal 2026 second quarter (ending February 26), representing a staggering 196% year-ove
With a Major Strategic Shift Announced, Is Suncor Still Canada’s Energy Blue-Chip Pick?
Is Canada’s “blue-chip energy stock” still worth holding amid its massive transformation? Let’s chat — is Suncor still a core holding for you, or is this shift already priced in? To investors familiar with Canada’s energy market, $Suncor(SU)$has long been the epitome of a heavy-asset, highly-cyclical player. But this Tuesday, the oil-sands giant rewrote that narrative with a bold set of targets: by 2040, 60% of its bitumen production will come from in-situ technology, rather than traditional mining. The shift boils down to clear economics. “Not all barrels are created equal,” Suncor CEO Rich Kruger stated plainly at the company’s Investor Day. Today, in-situ operations generate twice the cash flow per barrel compared to mining. Take
Gold Plunges Over 13% in March, But Gold Stocks Refuse to Follow — Is the Tide Turning?
💬 Gold & mining investors: Gold crashed but gold stocks held strong. Is this the classic “divergence bottom” signal? Let’s debate! $Gold - main 2606(GCmain)$ suffered a brutal collapse in March, plunging more than 13% — its worst monthly drop since the 2008 financial crisis. Yet gold stocks showed remarkable resilience: they did not sell off in lockstep, and some top miners even posted double-digit gains late in the month. Gold fell hard, but gold stocks did not. Is this just a temporary divergence… or is the market quietly shifting direction? Independent analyst Ross Norman described late-March gains as a mere “dead cat bounce,” bluntly stating it “was not a real rebound at all.” The core driver of the crash was a dramatic
💬 Commodity & mining investors: Trump just overhauled steel/aluminum/copper tariffs. How will this shift domestic mining, supply chains, and your portfolio? Let’s break it down! On April 2, the Trump administration announced a major overhaul of tariffs on imported metals. While keeping the steep 50% tariff on steel, aluminum, and copper products, it introduced for the first time a tiered exemption system based on metal content to ease compliance pressure for businesses. Under the new rules, imported goods with less than 15% total steel, aluminum, or copper content will be fully exempt from metal tariffs, according to the White House. Derivative products deemed “primarily made” of the metals will face a 25% tariff; products processed overseas using only U.S.-sourced metals will be taxed
Wave Life Sciences Weight-Loss Drug Phase 1 Data Sparks Volatility
💬 Biotech & GLP-1 investors: Did WVE crash too hard on Phase 1 data? Can a muscle-sparing, visceral-fat-targeted drug still win in obesity? Let’s debate! Shares of small biotech company $WAVE Life Sciences(WVE)$ have plunged recently after the firm released Phase 1 clinical trial results for its experimental weight-loss drug, WVE-007. The market reacted negatively, with bears arguing the data were underwhelming and unlikely to position the candidate as a strong competitor in the fast-growing anti-obesity therapy market. However, the trial results may be far less disappointing than the market sell-off suggests. First, a critical distinction: not all body fat is the same. For overweight or obese patients, the most dangerous fat is
The Autonomous Driving Era Is Accelerating — These 3 Companies Could Be Big Winners
💬 Auto & Tech Investors: The self-driving revolution is HERE! Which company do you think will dominate the autonomous future? Let’s debate! In the U.S. and around the world, autonomous driving technology is advancing rapidly in both capability and scale. Companies leading this transformation are poised to expand just as quickly. The rise of self-driving vehicles represents one of the greatest transformations in transportation history, potentially offering investors a once-in-a-generation opportunity. However, choosing the right companies can be a challenge. Below are three stocks that are expected to thrive as autonomous vehicles go mainstream. Commercial Trucking Sector Autonomous trucking is among the most compelling segments in autonomous driving, and Aurora Innovation (AUR) is a pi
Can Gold Double Again to $10,000/Ounce? Analysts Divided
💬 Gold investors: $10,000 gold — fantasy or inevitable? Where do you stand in this wild debate? Let’s hear your price target! Gold hit an all-time high of roughly **$5,600 per ounce** in January this year — more than double the level of around $2,600 at the end of 2024. As of press time, gold has pulled back to approximately $4,800 an ounce. Even so, a growing number of prominent analysts, business leaders, and investors — including Jamie Dimon, CEO of JPMorgan Chase — believe gold could nearly double again to $10,000 per ounce in the near future. Why Did Gold Surge Over the Past Two Years? $Gold - main 2606(GCmain)$ In 2022 and 2023, the Federal Reserve raised interest rates to fight inflation. This pressure strengthened the U
Humans Return to the Moon – Canadian Space Stocks Face a Historic Opportunity
💬 Space investors: The moon race is back! Which Canadian space stock is your top pick for the Artemis era? Let’s discuss the next giant leap for markets! Half a century after the last Moon landing, humanity is heading back to the Moon. NASA’s Artemis II crewed lunar orbital mission is entering the final countdown. This is not only a milestone in space history but also seen by Canada’s investment community as the starting gun for a domestic space economy boom. As Canada’s first astronaut, Jeremy Hansen, prepares to fly to the Moon, Canada’s AI-powered robotic arm Canadarm3 will be deployed to the Lunar Gateway space station in the coming years. Capital markets have already reacted: space-related stocks on the Toronto Stock Exchange are trading actively. Canada is upgrading from a “space par